C-RAD AB – Delårsrapport jan-jun 2019
August 30, 2019 02:30 ET
|
C-Rad AB
REKORDHÖG ORDERSTOCK KVARTALET APRIL-JUNI 2019 Orderingång: 64,1 (56,4) MkrOrderstock: 214,5 (156,5) MkrIntäkter: 51,5 (51,9) MkrEBITDA: 1,9 (3,1) MkrRörelseresultat: -0,6 (2,0) Mkr.Resultat efter...
Reminder: C-RAD Web Presentation Half-Year Report 2019
August 26, 2019 02:30 ET
|
C-Rad AB
Presentation of the report for the first half of the fiscal year 2019: Date: Friday August 30, 2019 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-year report 2019 Procedure: Please...
C-RAD och Mevion lanserar integration för förbättrad behandlingskvalitet inom protonterapi
August 12, 2019 07:00 ET
|
C-Rad AB
C-RAD och Mevion Medical Systemsâ meddelar i dag en integration mellan C-RADs Catalyst PT™ och MEVIONs S250i Proton Therapy System®. Föreningen av de båda produkterna stödjer ett sömlöst arbetsflöde...
C-RAD and Mevion Release Integration for Improved Treatment Quality in Proton Therapy
August 12, 2019 07:00 ET
|
C-Rad AB
C-RAD and Mevion Medical Systemsâ announced today the integration between the C-RAD Catalyst PT™ and the MEVION S250i Proton Therapy System ®. The union of both products supports a seamless workflow...
C-RAD Web Presentation Half-Year Report 2019
August 09, 2019 02:30 ET
|
C-Rad AB
Presentation of the report for the first half of the fiscal year 2019: Date: Friday August 30, 2019 / kl. 11:00 Venue: Online Presentation Topic: C-RAD Half-year report 2019 Procedure: Please...
Patent- och Marknadsdomstolen vid Stockholms Tingsrätt lämnar beslut i ärende där C-RAD yrkat på bättre rätt till Beamocular’s patent
July 26, 2019 07:00 ET
|
C-Rad AB
Patent- och Marknadsdomstolen vid Stockholms Tingsrätt bekräftar C-RADs rätt till uppfinningen som beskrivs i patentansökan benämnd “Ionizing radiation detecting device” i domslutet som publicerats i...
Stockholm Patent and Market court resolution of dispute over C-RAD’s claim for Beamocular patent
July 26, 2019 07:00 ET
|
C-Rad AB
The Stockholm Patent and Market court confirmed C-RAD’s entitlement to the patent application “Ionizing radiation detecting device” in its verdict published today. C-RAD filed a patent entitlement...
MVZ Prof. Dr. Uhlenbrock and Partner väljer C-RADs innovativa SIGRT-lösning
July 17, 2019 05:00 ET
|
C-Rad AB
C-RAD informerar idag om en order på C-RADs ytskanningslösning baserad på Catalyst HD™ och Sentinel 4DCT™ från MVZ Prof. Dr. Uhlenbrock and Partner GmbH i Dortmund, Tyskland. MVZ Uhlenbrock &...
MVZ Prof. Dr. Uhlenbrock and Partner decides for C-RAD’s innovative SIGRT solution
July 17, 2019 05:00 ET
|
C-Rad AB
C-RAD announced today an order for its surface tracking solution based on Catalyst HD™ and Sentinel 4DCT™ for MVZ Prof. Dr. Uhlenbrock and Partner GmbH in Dortmund Germany. MVZ Uhlenbrock &...
C-RAD and Elekta sign agreement to distribute C-RAD’s cutting-edge SIGRT solutions in America
July 12, 2019 01:30 ET
|
C-Rad AB
C-RAD and Elekta announced today a sales and distribution agreement for the North American and Mexican market. The agreement enables Elekta to offer C-RAD’s surface image guided radiation therapy...